Orchestrating the rollout of capabilities to coincide with the approval of the new therapy can make all the difference for a successful launch.
You know you need new capabilities and you know you need technology to support those capabilities.
This is a critical time for your organization. Triverus Launch Services help insure you have the right capabilities at the right time. Our proven approach, accelerator assets and experienced teams help you ensure readiness and execute the plan.
Our Launch Readiness Service answers the questions “what do you need” and “when do you need it”. We follow our proven approach to create a detailed roadmap of initiatives that are right-sized for your organization.
Talk to one of our expertsOur Launch PMO Service helps you execute the roadmap. Some organizations have an existing IT team and others are building from scratch. We meet you where you are and bring experienced professionals and partner relationships to form the core of your Launch PMO team.
Talk to one of our expertsIn addition to our Launch Services, we can support Life Sciences companies in a number of ways. We combine our Technology Services with our Life Sciences expertise to bring you industry-focused solutions to common challenges.
These services take many different forms and often include:
Triverus worked with a Life Sciences company on a Data Protection Strategy following the launch of their first commercial product. As part of this engagement, Triverus led the assessment of the client’s information exposure and developed an actionable set of initiatives to address the information protection needs of the client’s growing business.
The Finance Department required a significant effort to reconcile the value of inventory in the inventory sub-ledger and the general ledger. Failure to complete this reconciliation could create risk for Sarbanes-Oxley compliance.
Triverus helped a Life Sciences company understand their current state of information storage, transfer and access, identified potential risks and recommended future state improvements to the organization’s data access and protection.
A biotechnology company focusing on clinical stage pharmaceuticals was embarking on a journey to mature how it handles and manages information. Their goal is to provide access to the appropriate information to the appropriate stakeholders in a secure and readily accessible manner, however based on recent events there was increased urgency to mature the Information Asset Management (IAM) process to address the following challenges:
At a pre-commercial biotechnology company, Triverus was engaged to execute a Commercial Launch Roadmap engagement. At the time, the client was 12 months from launch but had no IT presence in the organization. Triverus met with business leadership across the commercial, supply chain, medical, market access, finance and HR groups to determine the needs of the biotechnology company and define a right-sized roadmap and budget for launch.
A clinical-stage biopharmaceutical company, focused on developing therapies to improve the lives of patients diagnosed with cancer, received “priority status” for its first approval. Being fast-tracked for approval heightened the need to quickly transform the company from a clinical development organization to a commercial one.
A biopharmaceutical company had defined a strategic goal of simplifying and enhancing its global regulatory compliance capabilities. The company had adopted several compliance tools but had yet to define the required business rules and configure the tools effectively across their organization.
Triverus worked with the organization to assess its current data governance capabilities and implement a program to meet the company’s data privacy and records management goals within three quarters.
